{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:04:07Z","timestamp":1761933847039,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.iccl.2021.11.011","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T16:44:06Z","timestamp":1646930646000},"page":"219-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Future of LAAC\u2014In 5, 10, and 20\u00a0Years"],"prefix":"10.1016","volume":"11","author":[{"given":"Matthew J.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Parry-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iccl.2021.11.011_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3181\/00379727-66-16084P","article-title":"Amputation of the canine atrial appendages","volume":"66","author":"Hellerstein","year":"1947","journal-title":"Proc Soc Exp Biol Med"},{"issue":"9","key":"10.1016\/j.iccl.2021.11.011_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1949.02900440011003","article-title":"Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli","volume":"140","author":"Madden","year":"1949","journal-title":"J\u00a0Am Med Assoc"},{"issue":"22","key":"10.1016\/j.iccl.2021.11.011_bib4","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.iccl.2021.11.011_bib5","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/01.CIR.0000015698.54752.6D","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience","volume":"105","author":"Sievert","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2021.11.011_bib6","first-page":"417","article-title":"Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation","volume":"60","author":"Meier","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2021.11.011_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised noninferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iccl.2021.11.011_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2021.11.011_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"AMPLATZER\u2122 AMULET\u2122 left atrial appendage Occluder versus watchman\u2122 device for stroke prophylaxis (amulet ide): a randomized controlled trial","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.iccl.2021.11.011_bib10","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.iccl.2021.11.011_bib11","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.jacc.2020.05.019","article-title":"Transcatheter left atrial appendage occlusion in the DOAC era","volume":"75","author":"Price","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.iccl.2021.11.011_bib12","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2021.11.011_bib13","unstructured":"Sievert K, Asmarats L, Arzamendi D. LAAO the strengths and weaknesses of the lobe only occluder concept in theory and in practice. Interv Cardiol Clin, in press."},{"key":"10.1016\/j.iccl.2021.11.011_bib14","unstructured":"Wong I, Tzikas A, S\u00f8ndergaard L, et al. The strengths and weaknesses of the LAA covering disc occluders \u2013 conceptually and in practice. Interv Cardiol Clin, in press."},{"issue":"11","key":"10.1016\/j.iccl.2021.11.011_bib15","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.4244\/EIJ-D-19-01027","article-title":"WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry","volume":"16","author":"Ledwoch","year":"2020","journal-title":"Eurointervention"},{"issue":"11","key":"10.1016\/j.iccl.2021.11.011_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","article-title":"Rationale and choice of antithrombotic therapy following left atrial appendage closure","volume":"12","author":"Saw","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.iccl.2021.11.011_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jcin.2019.02.003","article-title":"Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER amulet observational study","volume":"12","author":"Aminian","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2021.11.011_bib18","first-page":"968.e13","article-title":"Impact of flow dynamics on device-related thrombosis after left atrial appendage occlusion","volume":"36","author":"Mill","year":"2020","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2021.11.011_bib19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.iccl.2021.11.011_bib20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.iccl.2021.11.011_bib21","unstructured":"Lee RJ, Hanke T. The strengths and weaknesses of LAA ligation or exclusion (LARIAT, ATRIA-CLIP, Surgical suture). Interv Cardiol Clin, in press."},{"issue":"9766","key":"10.1016\/j.iccl.2021.11.011_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"issue":"Supplement_1","key":"10.1016\/j.iccl.2021.11.011_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz745.0898","article-title":"VECTOR-HF: The first human experience with the V-LAP, a wireless left atrial pressure monitoring system for patients with heart failure","volume":"40","author":"Sievert","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.iccl.2021.11.011_bib24","doi-asserted-by":"crossref","first-page":"e001600","DOI":"10.1136\/openhrt-2021-001600","article-title":"Triage-HF Plus investigators. Lockdown, slow down: impact of the COVID-19 pandemic on physical activity-an observational study","volume":"8","author":"Taylor","year":"2021","journal-title":"Open Heart"},{"issue":"19","key":"10.1016\/j.iccl.2021.11.011_bib25","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.jacc.2021.03.307","article-title":"Vascular lesion-specific drug delivery systems: JACC state-of-the-art review","volume":"77","author":"Marlevi","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.iccl.2021.11.011_bib26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1161\/CIRCULATIONAHA.119.040860","article-title":"Recurrence of device-related thrombus after percutaneous left atrial appendage closure","volume":"140","author":"Asmarats","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2021.11.011_bib27","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.iccl.2021.11.011_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.13005\/bpj\/1413","article-title":"Rhythm versus rate control for atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"11","author":"Abushouk","year":"2018","journal-title":"Biomed Pharmacol J"},{"issue":"11","key":"10.1016\/j.iccl.2021.11.011_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2021.11.011_bib30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2021.11.011_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2021.11.011_bib32","first-page":"zwab018","article-title":"Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis","author":"Siddiqi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.iccl.2021.11.011_bib33","unstructured":"Cresti A, Toscana S, Camara O. Left atrial thrombus \u2013 are all atria and appendages equal? Interv Cardiol Clin, in press."},{"key":"10.1016\/j.iccl.2021.11.011_bib34","unstructured":"Nestelberger T, Alfadhel M, McAlister, C, et al. Follow up imaging after left atrial appendage occlusion \u2013 something or nothing, and for how long? Interv Cardiol Clin, in press."},{"issue":"1","key":"10.1016\/j.iccl.2021.11.011_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1097-0185(199805)251:1<87::AID-AR14>3.0.CO;2-7","article-title":"Morphological characteristics and distribution pattern of the arterial vessels in human cerebral cortex: a scanning electron microscope study","volume":"251","author":"Reina-De La Torre","year":"1998","journal-title":"Anat Rec"},{"issue":"5","key":"10.1016\/j.iccl.2021.11.011_bib36","first-page":"700","article-title":"Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience","volume":"77","author":"Park","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.iccl.2021.11.011_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00414-016-1486-1","article-title":"Pulmonary artery perforation and coronary air embolism-two fatal outcomes in percutaneous left atrial appendage occlusion","volume":"131","author":"Zwirner","year":"2017","journal-title":"Int J Leg Med"},{"issue":"2","key":"10.1016\/j.iccl.2021.11.011_bib38","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.ijcard.2014.04.260","article-title":"Close proximity between pulmonary artery and left atrial appendage leading to perforation of the artery, tamponade and death after appendage closure using cardiac plug device","volume":"175","author":"Hanazawa","year":"2014","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.iccl.2021.11.011_bib39","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.hrthm.2013.07.046","article-title":"Death from pulmonary artery erosion complicating implantation of percutaneous left atrial appendage occlusion device","volume":"10","author":"Sepahpour","year":"2013","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.iccl.2021.11.011_bib40","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.hrthm.2016.07.015","article-title":"Left atrial appendage and pulmonary artery anatomic relationship by cardiac-gated computed tomography: implications for late pulmonary artery perforation by left atrial appendage closure devices","volume":"13","author":"Halkin","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.iccl.2021.11.011_bib41","article-title":"Pulmonary artery perforation caused by a left atrial appendage closure device","author":"Lu","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2021.11.011_bib42","article-title":"Imaging risk features for device related pulmonary artery injury after left atrial appendage closure with Amplatzer\u2122 Amulet\u2122 device","author":"Praco\u0144","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.iccl.2021.11.011_bib43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jcin.2020.11.029","article-title":"Association of hospital procedural volume with outcomes of percutaneous left atrial appendage occlusion","volume":"14","author":"Nazir","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2021.11.011_bib44","first-page":"706","article-title":"The society for cardiovascular angiography and interventions structural heart disease early career task force survey results: endorsed by the society for cardiovascular angiography and interventions","volume":"80","author":"Marmagkiolis","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.iccl.2021.11.011_bib45","first-page":"779","article-title":"SCAI expert consensus statement for advanced training programs in pediatric and congenital interventional cardiac catheterization","volume":"84","author":"Armsby","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"16","key":"10.1016\/j.iccl.2021.11.011_bib46","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jcin.2020.04.013","article-title":"Role of teleproctoring in challenging and innovative structural interventions amid the COVID-19 pandemic and beyond","volume":"13","author":"Goel","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2021.11.011_bib47","first-page":"22","article-title":"Transseptal puncture: a step-by-step procedural guide","volume":"13","author":"Russo","year":"2019","journal-title":"Card Interventions Today"},{"key":"10.1016\/j.iccl.2021.11.011_bib48","first-page":"14","article-title":"Transatrial septal catheterization using a new radiofrequency probe","volume":"66","author":"Sherman","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2021.11.011_bib49","first-page":"1230","article-title":"Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair","volume":"97","author":"Sayah","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2021.11.011_bib50","unstructured":"Devgun J, De Potter T, Fabbricatore D, et al. Pre-Cath Lab Planning for Left Atrial Appendage Occlusion \u2013 Optional or Essential? Interv Cardiol Clin, in press."},{"key":"10.1016\/j.iccl.2021.11.011_bib51","unstructured":"Alkhouli M, Nielsen-Kudsk JE. The case for intracardiac echo to Guide left atrial appendage closure. Interv Cardiol Clin, in press."},{"issue":"4","key":"10.1016\/j.iccl.2021.11.011_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2021.11.011_bib53","unstructured":"Saraf K, Morris, GM. Left Atrial Appendage Closure: what the evidence does and does not reveal \u2013 a view from the outside. Interv Cardiol Clin, in press."},{"key":"10.1016\/j.iccl.2021.11.011_bib54","unstructured":"Ding WY, Lip GYH, Gupta D. Left atrial appendage occlusion \u2013 a choice or a last resort? How to\u00a0approach the patient. Interv Cardiol Clin, in press."},{"issue":"31","key":"10.1016\/j.iccl.2021.11.011_bib55","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"EWOLUTION investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"issue":"30","key":"10.1016\/j.iccl.2021.11.011_bib56","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.iccl.2021.11.011_bib57","doi-asserted-by":"crossref","first-page":"e0197583","DOI":"10.1371\/journal.pone.0197583","article-title":"Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis","volume":"13","author":"Makam","year":"2018","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.iccl.2021.11.011_bib58","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0000000000003886","article-title":"Outcome of intracerebral hemorrhage associated with different oral anticoagulants","volume":"88","author":"Wilson","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.iccl.2021.11.011_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1474-4422(21)00075-2","article-title":"Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies","volume":"20","author":"Li","year":"2021","journal-title":"Lancet Neurol"},{"journal-title":"Lancet Neurol","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","year":"2021","key":"10.1016\/j.iccl.2021.11.011_bib60"},{"issue":"Pt 2","key":"10.1016\/j.iccl.2021.11.011_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/brain\/aws349","article-title":"Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study","volume":"136","author":"B\u00e9jot","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.iccl.2021.11.011_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000513503","article-title":"Intracerebral hemorrhage recurrence in patients with and without cerebral amyloid angiopathy","volume":"11","author":"Pinho","year":"2021","journal-title":"Cerebrovasc Dis Extra"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745821001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745821001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:00:39Z","timestamp":1761933639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745821001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2211745821001152"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2021.11.011","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Future of LAAC\u2014In 5, 10, and 20\u00a0Years","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2021.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}